LAMEA Antibody Drug Conjugates Market Size Report to 2028

LAMEA Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application (Breast Cancer, Blood Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Technology, By Country and Growth Forecast, 2022 - 2028

Published Date: May-2022 | Number of Pages: 91 | Format: PDF | Report ID: KBV-18018

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


TABLE 1 LAMEA Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antibody Drug Conjugates Market
TABLE 4 Acquisition & mergers – Antibody Drug Conjugates Market
TABLE 5 Approvals and trials– Antibody Drug Conjugates Market
TABLE 6 LAMEA Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 7 LAMEA Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 8 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 9 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 10 LAMEA Blood Cancer Market by Country, 2018 - 2021, USD Million
TABLE 11 LAMEA Blood Cancer Market by Country, 2022 - 2028, USD Million
TABLE 12 LAMEA Urothelial Cancer & Bladder Cancer Market by Country, 2018 - 2021, USD Million
TABLE 13 LAMEA Urothelial Cancer & Bladder Cancer Market by Country, 2022 - 2028, USD Million
TABLE 14 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 15 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 16 LAMEA Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 17 LAMEA Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 18 LAMEA Cleavable Linker Market by Country, 2018 - 2021, USD Million
TABLE 19 LAMEA Cleavable Linker Market by Country, 2022 - 2028, USD Million
TABLE 20 LAMEA Non-Cleavable Linker Market by Country, 2018 - 2021, USD Million
TABLE 21 LAMEA Non-Cleavable Linker Market by Country, 2022 - 2028, USD Million
TABLE 22 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 23 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 24 LAMEA Antibody Drug Conjugates Market by Country, 2018 - 2021, USD Million
TABLE 25 LAMEA Antibody Drug Conjugates Market by Country, 2022 - 2028, USD Million
TABLE 26 Brazil Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 27 Brazil Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 28 Brazil Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 29 Brazil Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 30 Brazil Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 31 Brazil Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 32 Argentina Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 33 Argentina Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 34 Argentina Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 35 Argentina Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 36 Argentina Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 37 Argentina Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 38 UAE Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 39 UAE Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 40 UAE Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 41 UAE Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 42 UAE Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 43 UAE Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 44 Saudi Arabia Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 45 Saudi Arabia Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 46 Saudi Arabia Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 47 Saudi Arabia Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 48 Saudi Arabia Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 49 Saudi Arabia Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 50 South Africa Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 51 South Africa Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 52 South Africa Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 53 South Africa Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 54 South Africa Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 55 South Africa Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 56 Nigeria Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 57 Nigeria Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 58 Nigeria Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 59 Nigeria Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 60 Nigeria Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 61 Nigeria Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 62 Rest of LAMEA Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 63 Rest of LAMEA Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 64 Rest of LAMEA Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 65 Rest of LAMEA Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 66 Rest of LAMEA Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 67 Rest of LAMEA Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 68 Key Information – Takeda Pharmaceutical Company Limited
TABLE 69 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 70 KEY INFORMATION – ASTRAZENECA PLC
TABLE 71 Key Information – GlaxoSmithKline PLC
TABLE 72 Key Information – Pfizer, Inc.
TABLE 73 key information – Astellas Pharma, Inc.
TABLE 74 Key Information – Gilead Sciences, Inc.
TABLE 75 Key Information – Seagen Inc.
TABLE 76 Key Information – ADC Therapeutics SA
TABLE 77 Key Information – Daiichi Sankyo Company, Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2018, May – 2022, Mar) Leading Players
FIG 5 Recent strategies and developments: Takeda Pharmaceutical Company Limited
FIG 6 Recent strategies and developments: Gilead Sciences, Inc.

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities